Lifecore Biomedical Inc (LFCR)
6.28
-0.29
(-4.41%)
USD |
NASDAQ |
May 10, 16:00
6.296
+0.02
(+0.25%)
After-Hours: 20:00
Lifecore Biomedical Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
May 31, 2023 | -139.4% |
February 28, 2023 | -145.6% |
November 30, 2022 | -32.08% |
August 31, 2022 | -26.18% |
May 31, 2022 | -263.1% |
February 28, 2022 | -34.99% |
November 30, 2021 | -88.47% |
August 31, 2021 | -22.76% |
May 31, 2021 | 9.69% |
February 28, 2021 | -12.30% |
November 30, 2020 | -10.16% |
August 31, 2020 | -8.11% |
May 31, 2020 | 5.53% |
February 29, 2020 | -7.53% |
November 30, 2019 | -4.73% |
August 31, 2019 | -3.45% |
May 31, 2019 | -0.17% |
February 28, 2019 | 0.69% |
November 30, 2018 | -0.47% |
August 31, 2018 | 0.15% |
May 31, 2018 | 4.33% |
February 28, 2018 | 11.10% |
November 30, 2017 | 0.40% |
August 31, 2017 | 1.85% |
May 31, 2017 | 3.78% |
Date | Value |
---|---|
February 28, 2017 | 2.56% |
November 30, 2016 | 0.98% |
August 31, 2016 | 2.50% |
May 31, 2016 | 6.65% |
February 29, 2016 | -16.30% |
November 30, 2015 | 1.33% |
August 31, 2015 | 2.18% |
May 31, 2015 | 3.12% |
February 28, 2015 | 2.72% |
November 30, 2014 | 2.43% |
August 31, 2014 | 1.76% |
May 31, 2014 | 3.76% |
February 28, 2014 | 5.06% |
November 30, 2013 | 2.88% |
August 31, 2013 | 4.34% |
May 31, 2013 | 4.22% |
February 28, 2013 | 4.06% |
November 30, 2012 | 7.77% |
August 31, 2012 | 4.28% |
May 31, 2012 | 3.36% |
February 29, 2012 | 5.95% |
November 30, 2011 | 4.09% |
August 31, 2011 | 2.47% |
May 31, 2011 | -4.02% |
February 28, 2011 | 3.13% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-263.1%
Minimum
May 2022
9.69%
Maximum
May 2021
-46.11%
Average
-12.30%
Median
Feb 2021
Profit Margin (Quarterly) Benchmarks
Aquestive Therapeutics Inc | -106.4% |
SELLAS Life Sciences Group Inc | -- |
ADMA Biologics Inc | -23.88% |
Relmada Therapeutics Inc | -- |
Jaguar Health Inc | -398.7% |